Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
일요일, 9월 06

CME Group Inc

CMENASDAQ
Trade with Public
Trade with Public
$281.29
-0.76-0.27%
가까이에: Sep 4, 5:00 PM EST
$281.20
-0.0888-0.03%
시간외: Sep 4, 7:43 PM EST
배당금: 배당락일은 3일 후입니다
개요뉴스실적 전망이벤트목표가재무심리지분 현황배당금비교옵션주식 보고서

CME Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for CME Group (CME).

Price Target Range — 9 Quarters

Analyst Consensus — 17 Analysts

8Buy
6Hold
3Sell
Consensus RatingOutperform# Analysts17Avg. Consensus PT$279Upside to Avg. PT-0.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 3, 2026TD CowenBill KatzMaintainedBuy$292
Aug 19, 2026Deutsche BankBrian BedellDowngradeBuy→Hold$286→$270
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Reiterates Buy on CME Group, Maintains $292 Price Target

TD Cowen analyst Bill Katz reiterates CME Group (NASDAQ:CME) with a Buy and maintains $292 price target.
Benzinga Newsdesk

PRO
Deutsche Bank Downgrades CME Group to Hold, Lowers Price Target to $270

Deutsche Bank analyst Brian Bedell downgrades CME Group (NASDAQ:CME) from Buy to Hold and lowers the price target from $286 to $270.
Benzinga Newsdesk

PRO
B of A Securities Maintains Underperform on CME Group, Raises Price Target to $230

B of A Securities analyst Craig Siegenthaler maintains CME Group (NASDAQ:CME) with a Underperform and raises the price target from $226 to $230.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $330

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $324 to $330.
Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on CME Group, Lowers Price Target to $295

Piper Sandler analyst Patrick Moley maintains CME Group (NASDAQ:CME) with a Overweight and lowers the price target from $329 to $295.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Lowers Price Target to $324

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and lowers the price target from $353 to $324.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved